According to MannKind Corp's latest financial reports the company has -$0.25 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $-0.25 B | -1.74% |
2022-12-31 | $-0.26 B | 19.67% |
2021-12-31 | $-0.21 B | 16.03% |
2020-12-31 | $-0.19 B | -5.3% |
2019-12-31 | $-0.2 B | 8.82% |
2018-12-31 | $-0.18 B | -18.46% |
2017-12-31 | $-0.22 B | 16.96% |
2016-12-31 | $-0.19 B | -47.59% |
2015-12-31 | $-0.36 B | 374.89% |
2014-12-31 | $-73.77 M | 140.19% |
2013-12-31 | $-30.72 M | -72.25% |
2012-12-31 | $-0.12 B | -64.71% |
2011-12-31 | $-0.32 B | 69.06% |
2010-12-31 | $-0.19 B | 213.29% |
2009-12-31 | $-59.23 M | -168.28% |
2008-12-31 | $86.73 M | -76.18% |
2007-12-31 | $0.36 B | -5.06% |
2006-12-31 | $0.38 B | 85.28% |
2005-12-31 | $0.20 B | 37.65% |
2004-12-31 | $0.15 B | 34.76% |
2003-12-31 | $0.11 B | 22.92% |
2002-12-31 | $90.77 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | -36,371.16% | ๐บ๐ธ USA |
Novo Nordisk NVO | $15.78 B | -6,511.07% | ๐ฉ๐ฐ Denmark |
Eli Lilly LLY | $10.86 B | -4,513.12% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | -15,388.34% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $83.8 M | -134.05% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.13 B | -153.21% | ๐บ๐ธ USA |